OTC: NGENF - NervGen Pharma Corp.

Rentabilité sur six mois: +1.38%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions NervGen Pharma Corp.


À propos de l'entreprise NervGen Pharma Corp.

NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. The company's lead product candidate is NVG-291 that is in phase 1 clinical trial for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. It has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage.

plus de détails
The company was incorporated in 2017 and is based in Vancouver, Canada.

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.nervgen.com
Цена ао 1.85
Changement de prix par jour: 0% (1.84)
Changement de prix par semaine: -0.5405% (1.85)
Changement de prix par mois: -4.17% (1.92)
Changement de prix sur 3 mois: -15.98% (2.19)
Changement de prix sur six mois: +1.38% (1.815)
Changement de prix par an: +14.29% (1.61)
Evolution du prix sur 3 ans: +9.52% (1.68)
Evolution du prix sur 5 ans: +30.5% (1.41)
Evolution des prix depuis le début de l'année: -15.21% (2.17)

Sous-estimation

Nom Signification Grade
P/S 0 0
P/BV -51.72 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficacité

Nom Signification Grade
ROA, % -127.69 0
ROE, % 830 10
Total: 1.67

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA 0 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 0 0
Rentabilité Ebitda, % 1369.23 10
Rentabilité EPS, % -16.09 0
Total: 3.8



Superviseur Titre d'emploi Paiement Année de naissance
Mr. William Joseph Radvak BASc Co-Founder & Advisor 44.12k 1963 (62 année)
Dr. Harold Martin Punnett D.M.D. Co-Founder & Independent Director N/A
Dr. Daniel D. Mikol M.D., Ph.D. Chief Medical Officer 583.89k
Mr. Michael Kelly CEO, President & Director 544.43k 1966 (59 années)
Mr. Brian McAlister Co-Founder & Advisor N/A
Mr. William J. Adams C.A., CPA, CA, CPA CFO & Corporate Secretary 1962 (63 année)
Dr. Charles V. Olson D.Sc. Senior Vice President of Technical Operations 1957 (68 années)
Ms. Elizabeth Eberhardt B.Sc. Senior Vice President of Program Management

Adresse: Canada, Vancouver. BC VM X, 2955 Virtual Way - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.nervgen.com